Literature DB >> 837134

Angiotensin II in essential hypertension.

D G Beevers, J J Morton, C S Nelson, P L Padfield, M Titterington, M Tree.   

Abstract

Plasma concentrations of angiotensin II (PAC) were measured in a group of 146 hypertensive patients (diastolic pressure greater than 105 mm Hg) who had no apparent underlying cause for their condition and 113 randomly selected normotensive controls (diastolic pressure less than 90 mm Hg). There was no evidence of bimodality in the frequency distribution curves for plasma angiotensin II concentrations among the hypertensive patients. It was concluded that hypertension associated with low angiotensin II concentration and by implication "low-renin" hypertension is not a condition separate from essential hypertension.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 837134      PMCID: PMC1604827          DOI: 10.1136/bmj.1.6058.415

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  4 in total

1.  Estimation of angiotensin II concentration in human plasma by radioimmunoassay. Some applications to physiological and clinical states.

Authors:  G Düsterdieck; G McElwee
Journal:  Eur J Clin Invest       Date:  1971-11       Impact factor: 4.686

Review 2.  Low-renin hypertension.

Authors:  M J Dunn; R L Tannen
Journal:  Kidney Int       Date:  1974-05       Impact factor: 10.612

3.  Blood pressure in a Scottish town.

Authors:  V M Hawthorne; D A Greaves; D G Beevers
Journal:  Br Med J       Date:  1974-09-07

4.  Is low-renin hypertension a stage in the development of essential hypertension or a diagnostic entity?

Authors:  P L Padfield; J J Brown; A F Lever; M A Schalekamp; D G Beevers; D L Davies; J I Robertson; M Tree
Journal:  Lancet       Date:  1975-03-08       Impact factor: 79.321

  4 in total
  3 in total

1.  Effect of aminoglutethimide on blood pressure and steroid secretion in patients with low renin essential hypertension.

Authors:  A A Taylor; J R Mitchell; F C Bartter; W R Snodgrass; R J McMurtry; J R Gill; R B Franklin
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

2.  Captopril and atenolol combined with hydrochlorothiazide in essential hypertension.

Authors:  L Andrén; B Karlberg; P Ohman; A Svensson; J Asplund; L Hansson
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

3.  Converting enzyme activity and essential hypertension.

Authors:  A Overlack; M Higuchi; R Kolloch; K O Stumpe
Journal:  Klin Wochenschr       Date:  1983-04-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.